rs145017164
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_033056.4(PCDH15):c.1205G>C(p.Gly402Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000378 in 1,613,958 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G402S) has been classified as Uncertain significance.
Frequency
Consequence
NM_033056.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PCDH15 | NM_033056.4 | c.1205G>C | p.Gly402Ala | missense_variant | 11/33 | ENST00000320301.11 | |
PCDH15 | NM_001384140.1 | c.1205G>C | p.Gly402Ala | missense_variant | 11/38 | ENST00000644397.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PCDH15 | ENST00000320301.11 | c.1205G>C | p.Gly402Ala | missense_variant | 11/33 | 1 | NM_033056.4 | ||
PCDH15 | ENST00000644397.2 | c.1205G>C | p.Gly402Ala | missense_variant | 11/38 | NM_001384140.1 |
Frequencies
GnomAD3 genomes ? AF: 0.000795 AC: 121AN: 152154Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000414 AC: 104AN: 251458Hom.: 0 AF XY: 0.000368 AC XY: 50AN XY: 135896
GnomAD4 exome AF: 0.000334 AC: 488AN: 1461686Hom.: 2 Cov.: 32 AF XY: 0.000323 AC XY: 235AN XY: 727166
GnomAD4 genome ? AF: 0.000801 AC: 122AN: 152272Hom.: 0 Cov.: 33 AF XY: 0.000766 AC XY: 57AN XY: 74454
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 10, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 29, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 30, 2021 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Identified heterozygous in an individual with nonsyndromic hearing loss who also harbored variants in two other hearing loss-associated genes (Besnard et al., 2014).; This variant is associated with the following publications: (PMID: 24498627) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jan 13, 2023 | BS1_supporting - |
Usher syndrome type 1D;C1836027:Autosomal recessive nonsyndromic hearing loss 23;C1865885:Usher syndrome type 1F Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 21, 2017 | Variant classified as Uncertain Significance - Favor Benign. The p.Gly402Ala var iant in PCDH15 has been reported in the heterozygous state in 1 individual with hearing loss (Besnard 2014). It has also been identified in 0.26% (62/24036) of African chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.br oadinstitute.org; dbSNP rs145017164). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic r ole. Computational prediction tools and conservation analysis do not provide str ong support for or against an impact to the protein. In summary, while the clini cal significance of the p.Gly402Ala variant is uncertain, its frequency suggests that it is more likely to be benign. ACMG/AMP Criteria applied: BS1_supporting. - |
Usher syndrome type 1F Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Pars Genome Lab | May 18, 2021 | - - |
Usher syndrome type 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at